Polyvalent hiv-1 immunogen

US2016115205A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016115205-A1
Application numberUS-201414784496-A
CountryUS
Kind codeA1
Filing dateApr 15, 2014
Priority dateApr 15, 2013
Publication dateApr 28, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.

First claim

Opening claim text (preview).

What is claimed is: 1 . A composition comprising an HIV-1 envelope AA104.0 ( FIG. 6 , SEQ ID NO: 1), AA107.0 ( FIG. 6 , SEQ ID NO: 2), AA058.1 ( FIG. 6 , SEQ ID NO:3), or a combination thereof. 2 . The composition of claim 1 comprising AA104.0 (SEQ ID NO: 1), AA107.0 (SEQ ID NO: 2) and AA058.1(SEQ ID NO:3). 3 . The composition of claim 1 or 2 , wherein the envelope is a gp120Delta N-terminus polypeptide from SEQ ID NOs: 1, 2 or 3. 4 . The composition of any one of claims 1 - 3 , further comprising HIV-1 envelope B.6240 gp120D11 and A244 gp120 D11. 5 . A composition comprising the gp120Delta N-terminus polypeptide from AA104.0 ( FIG. 6 , SEQ ID NO: 1), AA107.0 ( FIG. 6 , SEQ ID NO: 2), AA058.1 ( FIG. 6 , SEQ ID NO: 3), B.6240 gp120D11 and A244 gp120 D11. 6 . The composition of any one of claims 1 - 5 , wherein the envelope is a recombinant protein. 7 . A composition comprising a nucleic acid encoding any one of envelopes of AA104.0 ( FIG. 6 , SEQ ID NO: 1), AA107.0 ( FIG. 6 , SEQ ID NO: 2), AA058.1 ( FIG. 6 , SEQ ID NO: 3), or the gp120Delta N-terminus polypeptide therefrom. 8 . The composition of claims 1 - 5 further comprising an adjuvant. 9 . The composition of claim 8 , wherein the adjuvant is a Toll-like receptor 4 agonist glucopyranosyl lipid adjuvant-stable emulsion (GLA/SE). 10 . A method of inducing an immune response in a subject comprising administering to the subject the composition of any one of claim 1 or 5 in an amount sufficient to effect the induction. 11 . The method of claim 10 wherein the composition is administered as a boost.

Assignees

Inventors

Classifications

  • for HIV · CPC title

  • Multivalent vaccine · CPC title

  • Viral antigens · CPC title

  • Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein · CPC title

  • C07K14/005Primary

    from viruses · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016115205A1 cover?
The present invention relates, in general, to human immunodeficiency virus-1 (HIV-1) particular, to a polyvalent vaccine for HIV-1 and to methods of making and using same.
Who is the assignee on this patent?
Univ Duke, Government Of The U S As Represented By The Secretary Of The Army On Behalf Of Walter Reed A, Jackson H M Found Military Med, and 1 more
What technology area does this patent fall under?
Primary CPC classification C07K14/005. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Apr 28 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).